Literature DB >> 30450660

Localized primary malignant pericardial mesothelioma.

Guang Song1, Wenjing Bi1, Xintong Zhang1, Wanying Huang2, Ke Zhou3, Weidong Ren1.   

Abstract

Primary malignant pericardial mesothelioma (PMPM) is an extremely rare tumor, which may appear as a localized or a diffuse mass encasing the heart. Diffuse PMPMs have a poor prognosis due to the difficulty of surgical excision, whereas localized PMPMs have clear margins, thus facilitating surgical excision. Timely diagnosis and proper treatment are crucial for a favorable prognosis. Eight cases of localized PMPMs have been reported so far, but their characteristics have not been fully described. Herein, we present a patient with localized PMPM and describe the diagnosis methods, treatment, and outcomes of these tumors.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  echocardiography; pericardium; primary malignant mesothelioma

Mesh:

Substances:

Year:  2018        PMID: 30450660     DOI: 10.1002/jcu.22673

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  2 in total

1.  A survivor woman after three years of a cardiac tamponade.

Authors:  Ana Lilia Peralta-Amaro; Adriana Vázquez-Hernández; Guadalupe Morales-Osorio; Emily Pecero-García; Salma Triana-González; Fernanda Manzo-Carballo; Elsa Acosta-Jiménez
Journal:  J Cardiol Cases       Date:  2021-11-22

Review 2.  Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.

Authors:  Alberto M Marchevsky; Andras Khoor; Ann E Walts; Andrew G Nicholson; Yu Zhi Zhang; Victor Roggli; John Carney; Anja C Roden; Henry D Tazelaar; Brandon T Larsen; Nolwenn LeStang; Lucian R Chirieac; Sonja Klebe; Ming-Sound Tsao; Marc De Perrot; Andrew Pierre; David M Hwang; Yin P Hung; Mari Mino-Kenudson; William Travis; Jennifer Sauter; Mary Beth Beasley; Françoise Galateau-Sallé
Journal:  Mod Pathol       Date:  2019-09-04       Impact factor: 7.842

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.